Pharmacodynamics of Radiolabelled Anticancer Drugs for Positron Emission Tomography

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|11|931-944

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.11, 2003-04, pp. : 931-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Radiolabelled Anticancer Drugs for Positron Emission Tomography

By  

Current Pharmaceutical Design, Vol. 9, Iss. 11, 2003-04 ,pp. : 917-929

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabelled Molecules for Imaging the Translocator Protein (18 kDa) Using Positron Emission Tomography

By  

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2899-2923

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Positron Emission Tomography

By  

Heart Drug, Vol. 2, Iss. 3, 2002-07 ,pp. : 117-126

Karger

Access to resources Recommend Favorite

Radiofluorinated Carbohydrates for Positron Emission Tomography

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-04 ,pp. : 944-950

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabelled Tracers and Anticancer Drugs for Assessment of Therapeutic Efficacy Using PET

By  

Current Pharmaceutical Design, Vol. 7, Iss. 18, 2001-12 ,pp. : 1863-1892

Bentham Science Publishers

Access to resources Recommend Favorite